NeurOp, Inc. is a biotechnology company developing new medicines for central nervous system disorders including depression, neuropathic pain, ischemia (stroke), schizophrenia and Parkinson’s disease.
Latest News
NeurOp Selected to Compete in RESI 2017 Innovation Challenge - Sept 26th, Boston
Our Science
Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.
About Us
Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.